Clinical trial
Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS)
NCT06092736 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS)
- Lead sponsor
- Qilu Hospital of Shandong University
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- December 18, 2018
- Completion date
- June 30, 2028
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.